Impaired vasodilator activity in deoxycorticosterone acetate-salt hypertension is associated with increased protein O-GlcNAcylation

Hypertension

Volumn 53, Issue 2, 2009, Pages 166-174

  Lima, Victor V ^a   Giachini, Fernanda R C ^a,b   Choi, Hyehun ^a   Carneiro, Fernando S ^a,b   Carneiro, Zidonia N ^a   Fortes, Zuleica B ^b   Carvalho, Maria Helena C ^b   Webb, R Clinton ^a   Tostes, Rita C ^a,b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

DOCA salt; eNOS; O linked N acetylglucosaminylation; Vascular reactivity

Indexed keywords

ACETYLCHOLINE; CARBAMIC ACID DERIVATIVE; DEOXYCORTICOSTERONE ACETATE; FRUCTOSE 6 PHOSPHATE; FRUCTOSE 6 PHOSPHATE AMIDOTRANSFERASE; GLUTAMINE; N ACETYL BETA GLUCOSAMINIDASE; N ACETYLGLUCOSAMINE; N ACETYLGLUCOSAMINYLTRANSFERASE; NITRIC OXIDE SYNTHASE; O (2 ACETAMIDO 2 DEOXY DEXTRO GLUCOPYRANOSYLIDENE)AMINO N PHENYLCARBAMATE; O LINKED BETA N ACETYLGLUCOSAMINASE INHIBITOR; O LINKED BETA N ACETYLGLUCOSAMINE TRANSFERASE; PHENYLEPHRINE; PROTEIN KINASE B; SERINE; SODIUM CHLORIDE; UNCLASSIFIED DRUG; BETA N ACETYLHEXOSAMINIDASE; DEOXYCORTICOSTERONE; GLUTAMINE FRUCTOSE 6 PHOSPHATE AMINOTRANSFERASE; HEXOSAMINIDASE C; UDP N ACETYLGLUCOSAMINE PEPTIDE BETA N ACETYLGLUCOSAMINYLTRANSFERASE; UDP-N-ACETYLGLUCOSAMINE-PEPTIDE BETA-N-ACETYLGLUCOSAMINYLTRANSFERASE; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

ACETYLATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; BLOOD VESSEL REACTIVITY; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFECT; ENDOTHELIUM; FREQUENCY MODULATION; GLUCOSE BLOOD LEVEL; HEART CONTRACTION; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE RELAXATION; UNINEPHRECTOMY; VASCULAR DISEASE; VASOCONSTRICTION; VASODILATATION; ANIMAL; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; MESENTERIC ARTERY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; THORACIC AORTA; WISTAR RAT;

ACETYLCHOLINE; ANIMALS; AORTA, THORACIC; BETA-N-ACETYLHEXOSAMINIDASES; DESOXYCORTICOSTERONE; DISEASE MODELS, ANIMAL; GLUTAMINE-FRUCTOSE-6-PHOSPHATE TRANSAMINASE (ISOMERIZING); HYPERTENSION; MALE; MESENTERIC ARTERIES; N-ACETYLGLUCOSAMINYLTRANSFERASES; PHENYLEPHRINE; RATS; RATS, WISTAR; VASOCONSTRICTOR AGENTS; VASODILATION; VASODILATOR AGENTS;

EID: 59849122422     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.108.116798     Document Type: Article

References (18)

1. Rodgers A, Ezzati M, Vander Hoorn S, Lopez AD, Lin RB, Murray CJ. Comparative Risk Assessment Collaborating Group. Distribution of major health risks: findings from the Global Burden of Disease study. PLoS Med. 2004;l:e27.
2. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365:217-223.
3. American Heart Association and American Stroke Association. Heart disease and stroke statistics-2007 update. Available at: www.american-heart.org/ downloadable/heait/1166712318459HS-StatsInsideText.pdf. Accessed April 10, 2008.
4. Hart GW, Housley MP, Slawson C. Cycling of O-linked β-N- acetylglucosamine on nucleocytoplasmic proteins. Nature. 2007;446:1017-1022.
5. Fülöp N, Marchase RB, Chatham JC. Role of protein O-linked N-acetyl-glucosamine in mediating cell function and survival in the cardiovascular system. Cardiovasc Res. 2007;73:288-297.
6. Goldberg HJ, Whiteside CI, Hart GW, Fantus IG. Posttranslational, reversible O-glycosylation is stimulated by high glucose and mediates plasminogen activator inhibitor-1 gene expression and Spl transcriptional activity in glomerular mesangial cells. Endocrinology. 2006; 147:222-231.
7. Whitworth CE, Macauley MS, Stubbs KA, Dennis RJ, Taylor EJ, Davies GJ, Greig IR, Vocadlo DJ. Analysis of PugNag and NAG-thiazoline as transition state analogues for human O-GlcNAcase: mechanistic and structural insights into inhibitor selectivity and transition state poise. J Am Chem Soc. 2007;129:635-644.
8. Carneiro FS, Nunes KP, Giachini FR, Lima VV, Carneiro ZN, Nogueira EF, Leite R, Ergul A, Rainey WE, Clinton Webb R, Tostes RC. Activation of the ET-l/ETA pathway contributes to erectile dysfunction associated with mineralocorticoid hypertension. J Sex Med. 2008;5:2793-2807.
9. Giachini FR, Zemse SM, Carneiro FS, Lima VV, Carneiro ZN, Callera GE, Ergul A, Webb RC, Tostes RC. Interleukin-10 attenuates vascular responses to endothelin-1, via effects on ERKl/2-dependent pathway. Am J Physiol Heart Circ Physiol. 2008 [Epub ahead of print].
10. Chung SS, Kim JH, Park HS, Choi HH, Lee KW, Cho YM, Lee HK, Park KS. Activation of PPAR-γ negatively regulates O-GlcNAcylation of Spl. Biochem Biophys Res Commum. 2008;372:713-718.
11. Musicki B, Kramer MF, Becker RE, Burnett AL. Inactivation of phos-phorylated endothelial nitric oxide synthase (Ser-1177) by O-GlcNAc in diabetes-associated erectile dysfunction. Proc Natl Acad Sci USA. 2005;102:11870-11875.
12. Zachara NE, O'Donnell N, Cheung WD, Mercer JJ, Marth JD, Hart GW. Dynamic O-GlcNAc modification of nucleocytoplasmic proteins in response to stress. A survival response of mammalian cells. J Biol Chem. 2004;279:30133-30142.
13. Du XL, Edelstein D, Dimmeler S, Ju Q, Sui C, Brownlee M. Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. J Clin Invest. 2001;108:1341-1348.
14. Callera GE, Tostes RC, Yogi A, Montezano AC, Touyz RM. Endothelin-1-induced oxidative stress in DOCA-salt hypertension involves NADPH-oxidase-independent mechanisms. Clin Sci. 2006;110:243-253.
15. Northcott CA, Poy MN, Najjar SM, Watts SW. Phosphoinositide 3-kinase mediates enhanced spontaneous and agonist-induced contraction in aorta of deoxycorticosterone acetate-salt hypertensive rats. Circ Res. 2002;91:360-369.
16. Hart GW, Haltiwanger RS, Holt GD, Kelly WG. Glycosylation in the nucleus and cytoplasm. Annu Rev Biochem. 1989;58:841-874.
17. Comer FI, Hart GW. Reciprocity between O-GlcNAc and O-phosphate on the carboxyl terminal domain of RNA polymerase II. Biochemistry. 2001;40:7845-7852.
18. Chen L, Liu Y, Cui B, Mi Q, Huang Y, Fan L, Chen Q, Tang J, Ferro A, Ji Y. 17β-Oestradiol partially attenuates the inhibition of nitric oxide synthase-3 by advanced glycation end-products in human platelets. Clin Exp Pharmacol Physiol. 2007;34:972-978.